Morocco to Receive 2 Million Pfizer Vaccine Doses Through Israeli Mediation

Morocco has been able to vaccinate a large number of people, becoming one of the most advanced countries in terms of anti-Covid-19 vaccination, thanks to the vaccines Sinopharm, AstraZeneca and Johnson & Johnson. "Two million doses of the Pfizer-BioNTech vaccine" will be added to this list, thanks to the American-German cooperation. Access to the Pfizer-BioNTech vaccine has nevertheless "benefited from Israeli mediation," TelQuel specifies.

According to the World Health Organization, the Pfizer-BioNTech vaccine has "an efficacy of 95% against symptomatic SARS-CoV-2 infection." But recent studies by the New England Journal of Medicine indicate that the Pfizer-BioNTech vaccine has "an efficacy of 88% against symptomatic infection with the delta variant." A rate that reaches 93.7% for the alpha variant. The Pfizer-BioNTech vaccine is one of the vaccines recognized and accepted within the European Union.